InMed Pharmaceuticals annual operating margin
2021
2022
2023
InMed Pharmaceuticals Operating Margin Growth & History (INM)
InMed Pharmaceuticals's operating margin was −581.92% for fiscal 2023.
View full InMed Pharmaceuticals company overviewInMed Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-06-30 | −581.92% | +779.97 pp |
| 2022 | 2022-06-30 | −1,361.89% | −826.02 pp |
| 2021 | 2021-06-30 | −535.87% | — |
InMed Pharmaceuticals quarterly operating margin
Q2.21
Q3.21
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2024 | 2023-09-30 | −281.29% | +841.40 pp |
| Q3 2023 | 2023-03-31 | −193.24% | +1422.36 pp |
| Q2 2023 | 2022-12-31 | −447.25% | +261.97 pp |
| Q1 2023 | 2022-09-30 | −1,094.24% | −283.60 pp |
| Q3 2022 | 2022-03-31 | −1,122.69% | — |
| Q2 2022 | 2021-12-31 | −1,615.60% | — |
| Q3 2021 | 2021-03-31 | −709.22% | — |
| Q2 2021 | 2020-12-31 | −810.64% | — |
InMed Pharmaceuticals operating margin trends
Across the available reported history, InMed Pharmaceuticals's operating margin increased from −1,361.89% to −581.92%, a change of +779.97 percentage points. The latest reported quarter, Q1 2024, shows −281.29%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InMed Pharmaceuticals filings at SEC.gov ↗